Solid oral dosage form of testosterone derivative
AssigneeSolural Pharma ApS
InventorBent Højgaard
Life of this patent
Estimating the term…
Abstract
The present invention relates to a composition, particularly a pharmaceutical composition comprising a testosterone derivative having a log P of at least 5 and a vehicle, wherein the vehicle comprises a fat component in an amount sufficient to achieve lymphatic absorption in a mammal, wherein the fat component comprises a mono- or triglyceride of long chain fatty acids
Claims17
A composition comprising a testosterone undecanoate and a vehicle, wherein the vehicle comprises (a) a fat component in an amount sufficient to achieve lymphatic absorption in a mammal, wherein the fat component comprises a mono- or tri-glyceride or a mono- and tri-glyceride of long chain fatty acids.
Dependencies are inferred from the claim text.